Rare diseases
Investigational molecules
Locations
128 Spring Street Suite 500 Building C, 02421-7800, United States
Curis Inc. is active in acute myeloid leukemia and higher-risk myelodysplastic syndrome, with research centered on relapsed and refractory disease settings and molecularly defined subgroups.
The sponsor’s work in this area includes hematologic malignancies with a focus on difficult-to-treat myeloid cancers.
Curis Inc. runs clinical trials in conditions such as Chronic lymphocytic leukaemia, Haematological malignancy, Central nervous system lymphoma, Acute myeloid leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Italy
Czechia
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
